600129.SS

Chongqing Taiji Industry(Group) Co.,Ltd [600129.SS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

600129.SS Stock Summary

In the News

600129.SS Financial details

Company Rating
-
Market Cap
17.97B
Income
822.12M
Revenue
15.57B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
12.59K
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
28.08
Forward P/E
-
PEG
2.14
P/S
1.61
P/B
6.33
P/C
-
P/FCF
-40.56
Quick Ratio
0.52
Current Ratio
0.82
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.48
EPS next Y
-
EPS next Q
-
EPS this Y
131.25%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
5.8%
Revenue Q/Q
8.23%
EPS Q/Q
-65.71%
-
-
-
-
SMA20
-
SMA50
5%
SMA100
-16%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
25%
ROC
0.2%
Gross Margin
48%
Oper. Margin
7%
Profit Margin
5%
Payout
16%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
29.75-68.44
52W High
-69.72%
52W Low
-29%
RSI
47
Rel Volume
0.62
Avg Volume
15.69M
Volume
9.76M
Perf Week
1.03%
Perf Month
-6.02%
Perf Quarter
-22.71%
Perf Half Y
-20.9%
-
-
-
-
Beta
0.583
-
-
Volatility
0.23%, 0.62%
Prev Close
0%
Price
20.59
Change
0.44%

Something similar

Top by Market Cap
VTI
ABEA.DE
CMC.DE
V
BRH.DE
Same Sector
MOREPENLAB.NS
ALBERTDAVD.NS
002788.SZ
ITRM
SCIB.ST
Same Price Range
ESSARSHPNG.NS
XINC.TO
VCNS.TO
SOXL
LSGRX
Similar Market Cap
600012.SS
ARVSMART.NS
601069.SS
INDOTECH.NS
USFR

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 15.69M
  • Market Capitalization 17.97B
  • Employee 12.59K
  • CEO Mr. Min Yu
  • Headquarters Chongqing,CN
  • IPO Date 1997-11-18
  • Website https://www.taiji.com

Chongqing Taiji Industry(Group) Co.,Ltd operates in the pharmaceutical industry in China and internationally. It researches, develops, produces, and sells Chinese medicine and health products. The company offers its products in various dosage forms, including tablets, oral liquids, syrups, dripping pills, granules, capsules, tinctures, powders, etc. It offers its products in various areas, such as digestive system, respiratory system, cardiovascular and cerebrovascular, pediatrics and gynecology, systemic anti-infective drugs, analgesia and antibiotics, orthopedics, cold clearing and cough relief, and endocrine and nervous system drugs. The company is based in Chongqing, China.